Officials and policymakers say direct-to-consumer drug advertising encourages patients to seek treatments they don’t need and raises heath care costs, but the true picture is more nuanced.
HekaBio K.K., (Headquarters: Chuo-ku, Tokyo) announces that the innovative solid tumor treatment device 'Alpha DaRT (Diffusing Alpha Radiation Therapy),' developed by Alpha Tau Medical Ltd.